Bacillus methylotrophicus ASWU-C2, a strain inhabiting hot desert soil, a new source for antibacterial bacillopyrone, pyrophen, and cyclopeptides.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences
PMID:

Abstract

A strain of Bacillus methylotrophicus was isolated from a soil sample collected in Aswan eastern desert, which is known for its extremely arid climate. After fermentation of the strain in liquid culture and subsequent extraction, a bioassay-guided isolation procedure yielded five compounds: 2-benzyl-4H-pyran-4-one, named bacillopyrone (1), pyrophen (2), macrolactin A (3) and the cyclopeptides malformin A1 (4), and bacillopeptin A (5). The structures were determined by interpretation of nuclear magnetic resonance (NMR) spectroscopy and high resolution mass spectrometry (HR-MS) data. This is the first report on the isolation of compounds 1 and 2 from Bacillus species; compound 1 was reported previously as synthetic product. Bacillopyrone (1) exhibited moderate activity against the Gram-negative Chromobacterium violaceum with minimum inhibitory concentration 266.6 μg/mL, while macrolactin A (3) and malformin A1 (4) inhibited Staphylococcus aureus (minimum inhibitory concentrations 13.3 and 133.3 μg/mL, respectively).

Authors

  • Soleiman E Helaly
    Department of Chemistry, Faculty of Science, Aswan University, Aswan 81528, Egypt.
  • Zainab Hamad
    Department of Chemistry, Faculty of Science, Aswan University, Aswan 81528, Egypt.
  • Magdi A El Sayed
    Department of Botany, Faculty of Science, Aswan University, Aswan 81528, Egypt, Phone: 0020973480450.
  • Fatma F Abdel-Motaal
    Department of Botany, Faculty of Science, Aswan University, Aswan 81528, Egypt.
  • Mahmoud I Nassar
    Department of Chemistry of Natural Compounds, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt.
  • Shin-Ichi Ito
    Laboratory of Molecular Plant Pathology, College of Agriculture, Graduate School of Sciences and Technology for Innovation, Yamaguchi University, Yamaguchi, Japan.
  • Marc Stadler
    Department of Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, Braunschweig 38124, Germany.